Jay D. Kranzler, CEO at CYPRESS BIOSCIENCE INC (CYPB), sold 59,000 shares at $8.50 ($507K) on 2009-02-02, disclosed to the SEC on 2009-02-04.
Scheduled sale ($507k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.50 | 5,000 | $43K | 8.4% |
| 2 | $8.52 | 4,000 | $34K | 6.7% |
| 3 | $8.53 | 1,000 | $9K | 1.7% |
| 4 | $8.54 | 2,000 | $17K | 3.4% |
| 5 | $8.55 | 2,200 | $19K | 3.7% |
| 6 | $8.57 | 2,000 |
| $17K |
| 3.4% |
| 7 | $8.58 | 4,000 | $34K | 6.8% |
| 8 | $8.59 | 2,000 | $17K | 3.4% |
| 9 | $8.59 | 3,000 | $26K | 5.1% |
| 10 | $8.60 | 2,000 | $17K | 3.4% |
| 11 | $8.60 | 1,800 | $15K | 3.1% |
| 12 | $8.61 | 3,000 | $26K | 5.1% |
| 13 | $8.62 | 2,000 | $17K | 3.4% |
| 14 | $8.63 | 5,000 | $43K | 8.5% |
| 15 | $8.64 | 5,700 | $49K | 9.7% |
| 16 | $8.65 | 10,000 | $87K | 17.0% |
| 17 | $8.67 | 300 | $3K | 0.5% |
| 18 | $8.68 | 4,000 | $35K | 6.8% |
| Total | $8.60 avg | 59,000 | $507K | 100% |
| Filing → |
| CYPB | SELL | 2010-12-29 | $162K | — | Filing → |
| CYPB | SELL | 2010-12-29 | $983K | — | Filing → |
| CYPB | SELL | 2009-08-04 | $652K | — | Filing → |